top of page

Vocal.
Search


Pharma is in such a data mood today…
A few observations on our industry's appetite for data from a recent conversation between colleagues in Europe.

Ulrich Neumann, MBA MSc MA
Nov 21, 20196 min read


Prescription Drug Pricing: “The Times They Are A Changin”
The drug pricing debate in DC has intensified, and the pharmaceutical industry has become the prime target of bipartisan outrage.

Ulrich Neumann, MBA MSc MA
Nov 14, 20196 min read


'ICER' strikes again - Scandal time?
The drug-price watchdog ICER just issued a "Report on Unsupported Price Increases". The 'study' made the headlines, but it is problematic.

Ulrich Neumann, MBA MSc MA
Oct 9, 201910 min read


Real World Evidence: From Market Access to Drug Approval
This analysis outlines recent developments in the use of real-world evidence (RWE) and the sizeable impact it stands to make the industry.

Ulrich Neumann, MBA MSc MA
May 31, 20195 min read


PharmaVoice 'Year in Preview'- Interview
Thanks to the team at PharmaVoice for the interview for the "Year in Preview" issue. My two cents on multi-stakeholder commercial models.

Ulrich Neumann, MBA MSc MA
Nov 23, 20181 min read


The Shifting Landscape for Outcomes-Based Contracting – A US Market Assessment
Neumann, U. (2018). The Shifting Landscape for Outcomes-Based Contracting – A US Market Assessment (Whitepaper). Analytica Laser.

Ulrich Neumann, MBA MSc MA
Feb 28, 20181 min read


Blockchain in Pharma... Blockchain for Market Access? - 5 Thoughts
5 observations as to where we are today, and what might lie ahead for Blockchain in Pharmaceutical Market Access.

Ulrich Neumann, MBA MSc MA
Feb 3, 20184 min read


Class Cmm Drugs in Italy: Purchase and Prescription Behaviour in Hospitals
Value in Health, Vol. 21, Suppl. 3 S. 165, October, 2018 · Jan 1, 2018

Ulrich Neumann, MBA MSc MA
Jan 2, 20181 min read


Jack Whelan beat cancer.
Like anyone who knew him in our field, I am tragically saddened by the passing of Jack Whelan last Thursday. The fact that this day would ev

Ulrich Neumann, MBA MSc MA
Nov 21, 20171 min read


Payer-Pharma Perspectives on Outcomes-based Contracting. Stakeholder Insights.
Neumann, U. (2017). Payer-Pharma Perspectives on Outcomes-based Contracting. Stakeholder Insights. (Whitepaper). Analytica Laser.

Ulrich Neumann, MBA MSc MA
May 1, 20171 min read
Directly blog
bottom of page